Breath Gas Test System Model BA200

Portable breath analyzer for measuring fractional exhaled nitric oxide (FeNO) levels, used in clinical assessment of airway inflammation and asthma management. The device provides rapid, non-invasive diagnostic testing suitable for point-of-care and home-based monitoring applications.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.

A breath testing device designed for clinics, pharmacies, health screening centers, nursing homes, and community settings. It uses the same gas detection technology as hospital systems with interconnected diagnostic and treatment services, enabling hierarchical diagnosis and treatment of chronic respiratory diseases and cardiopulmonary health screening. It provides FeNO/CaNO/FeCO/FnNO testing for cough and asthma patients to optimize medication selection, reduce acute exacerbations and emergency hospitalization, and for susceptible populations for risk warning and disease prevention.

A breath analysis device for multi-molecular, multi-site, multi-parameter testing of respiratory and digestive conditions with complications. The CA series includes inflammatory phenotyping breath testing with NO baseline plus CO and H2S optional configurations, supporting online standard, offline, and tidal breath modes. It features breath quality control with standard gas and self-calibration, and is applicable to respiratory, pediatric, otolaryngology, surgery, radiology, and health screening departments for conditions including asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, nasal polyps, radiation pneumonitis, and perioperative pulmonary complications.

A multi-molecular, multi-site, multi-parameter breath analysis system for detecting inflammation and related conditions. The CA series includes multiple configurations (CA3478, CA3138, CA4458) that measure various exhaled gases including NO, CO, H2S, CH4, CO2, and O2 in different combinations. It supports online and offline sampling modes with quality control features, and is designed for respiratory, pediatric, ENT, surgical, radiology, and physical examination departments to diagnose conditions such as asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, and perioperative pulmonary complications.

Diagnostic system detecting nitric oxide in exhaled breath to evaluate airway inflammation and diagnose primary ciliary dyskinesia. Provides non-invasive assessment of respiratory tract conditions.

A breath analysis diagnostic system for measuring fractional exhaled nitric oxide levels, used to assess airway inflammation in respiratory diseases such as asthma. The platform integrates proprietary smart chip, smart algorithm, and smart manufacturing technologies for clinical and home-based testing.

A home-use breath analyzer designed for patients with chronic respiratory diseases and susceptible populations, featuring a mobile application and detection diagnostic treatment service card. It offers FeNO/FnNO self-testing capabilities using hospital-grade gas detection technology with interconnected diagnostic services, enabling chronic respiratory disease patients to reduce acute exacerbations and emergency hospitalization, and susceptible populations to reduce disease development risk.

Hospital-based exhaled nitric oxide (FeNO) detection system designed for patients with complications and critical illnesses. Enables multi-molecular, multi-airway exhaled gas combined testing to assess airway inflammation and dysbiosis markers for respiratory system disease precision medicine.

A breath diagnostic system that detects nitric oxide in exhaled breath to evaluate airway inflammation and diagnose ciliary dyskinesia.

An advanced breath analysis device for multi-molecular, multi-parameter inflammation and bacterial microbiota testing. The DA series includes configurations such as DA2123 with variable flow rate multi-parameter testing and DA7349 with NO, H2S, H2, CH4, CO, CO2, and O2 for comprehensive inflammation and microbiota breath testing plus AI olfactory diagnosis. It is designed for respiratory, digestive, allergy, and immunology departments for academic research and clinical applications including allergic rhinitis, asthma, irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, and gut-lung, gut-heart, gut-liver, and gut-brain axis dysbiosis conditions.

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.